Paid media for a pharmaceutical manufacturer is a narrow, heavily policed channel, and most of the money wasted in this category is wasted on the wrong platform. Google restricts pharmaceutical advertising by certification and geography, and Meta will decline most of what a formulation business wants to say. What remains is still commercially useful: search campaigns against molecule plus manufacturer queries, contract manufacturing and CDMO capability terms, PCD franchise recruitment across defined territories, and LinkedIn against procurement, sourcing and business development titles at buying companies. The measure is not cost per lead. It is how many of the enquiries reaching your technical desk arrived with a molecule, a quantity and a delivery timeline attached.
Paid media in pharma B2B is defined more by what you cannot run than by what you can. Google treats pharmaceutical advertising as a restricted category with certification requirements that differ by target country, so domestic sourcing and regulated export targeting sit in very different eligibility positions. Meta is largely closed to product-level pharmaceutical messaging, which pushes budget towards search and LinkedIn where the intent is stronger anyway. The genuinely convertible search inventory is narrow and cheap relative to consumer categories: molecule plus manufacturer, dosage form plus third party manufacturing, therapeutic division plus PCD franchise plus state, and CDMO capability terms tied to a dosage form or capacity. Franchise recruitment is the highest volume funnel and the easiest to run badly, because a poorly qualified campaign will fill your inbox with applicants who have no distribution network and no capital. Export campaigns are the slowest and need documentation-led landing pages covering dossier availability, registration support and realistic minimum order quantities. Welbourg Pharma is a published pharmaceutical client of ours, and we have worked with multiple brands in this category since 2017. We can share specific names and numbers on request.




























































